--- title: "The actual controller and chairman of BCC, Zheng Tiejian, is performing his duties normally" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/249284573.md" description: "According to the Zhitong Finance APP, BCC announced that on July 2, 2025, the company disclosed the \"Announcement on the Detention of the Actual Controller and Chairman.\" Currently, the actual controller and chairman, Mr. Zheng Tiejian, has returned to his position and is able to normally perform the duties of the company's legal representative and chairman, and the company's production and operations are normal" datetime: "2025-07-20T09:09:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/249284573.md) - [en](https://longbridge.com/en/news/249284573.md) - [zh-HK](https://longbridge.com/zh-HK/news/249284573.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/249284573.md) | [English](https://longbridge.com/en/news/249284573.md) # The actual controller and chairman of BCC, Zheng Tiejian, is performing his duties normally According to the Zhitong Finance APP, BCC (002455.SZ) announced that on July 2, 2025, it disclosed the "Announcement on the Detention of the Company's Actual Controller and Chairman." Currently, the actual controller and chairman, Mr. Zheng Tiejian, has returned to his position and is able to normally perform the duties of the company's legal representative and chairman, and the company's production and operations are normal ### 相關股票 - [BCC (002455.CN)](https://longbridge.com/zh-HK/quote/002455.CN.md) ## 相關資訊與研究 - [Ganfeng Lithium Shareholders Approve All Resolutions at 2026 Extraordinary Meeting](https://longbridge.com/zh-HK/news/278737752.md) - [Majestic Gold Resumes Operations at Songjiagou Open-Pit Mine](https://longbridge.com/zh-HK/news/278566032.md) - [Three vessels hit by projectiles in Strait of Hormuz](https://longbridge.com/zh-HK/news/278689964.md) - [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/zh-HK/news/278576491.md) - [12:23 ETFull Circles Therapeutics Highlights Circular Single-Stranded DNA Platform Enabling Immune-Evasive Genome Writing in Nature Study](https://longbridge.com/zh-HK/news/278753990.md)